Startseite The response to growth hormone treatment in a child with short stature, growth hormone deficiency and autosomal dominant cutis laxa type 3 – case report
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The response to growth hormone treatment in a child with short stature, growth hormone deficiency and autosomal dominant cutis laxa type 3 – case report

  • Mirela E. Iancu , Alice I. Albu EMAIL logo und Dragoș N. Albu
Veröffentlicht/Copyright: 1. Juli 2022

Abstract

Objectives

The aetiology of short stature in cutis laxa (CL) syndromes is largely unknown. Herein, we report a case with autosomal dominant CL type 3 (ADCL3) with severe short stature and growth hormone (GH) deficiency.

Case presentation

A male patient with a genetically confirmed diagnosis of ADCL3 was referred for endocrinological evaluation of short stature at the age of 3.4 years. The examination revealed severe proportional short stature (−4.14 standard deviations (SD) score for height) in a patient born small for gestational age (birth weight 2080 g, −2.46 SD, birth length 41 cm, −4.22 SD). Assessment of GH reserve with two clonidine stimulation tests (0.15 mg/m2) with peak GH values of 8.07 ng/mL and 2.98 ng/mL, respectively, were indicative of GH deficiency. Also, the MRI examination revealed a small size pituitary. Thus, the treatment with somatropin was started. The height deficit significantly improved (from −4.14 SD to −1.48 SD) without side effects during the follow-up of 4.5 years.

Conclusions

With this report, the GH deficiency as a possible cause of short stature in ADCL3 and the response to somatropin administration were reported for the first time in the literature.


Corresponding author: Alice I. Albu, MD, PhD, Assistant Professor of Endocrinology, Endocrinology Department, Elias Emergency Hospital, 17 Marasti Str. 3rd floor, Bucharest, Romania; and ‘Carol Davila’ University of Medicine and Pharmacy, Bucharest, Romania, E-mail:

Acknowledgments

We are grateful to all of the staff involved in the medical care of the patient.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Author DNA has received travel grants from Merck, Merck Sharp and Dohme and Ferring Parmaceuticals. Author AIA has received travel grants from Ferring Pharmaceuticals, Pfizer, speaker honorarium from Sandoz Pharma Services and lectures honorarium from Merck.

  4. Informed consent: Informed consent for the publication, medical evaluation and treatment was obtained from the patient’s parents.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Berk, DR, Bentley, DD, Bayliss, SJ, Lind, A, Urban, Z. Cutis laxa: a review. J Am Acad Dermatol 2012;66:842.e1–17. https://doi.org/10.1016/j.jaad.2011.01.004.Suche in Google Scholar

2. MSD Mannual Professional Version. Cutis laxa. Available from: https://www.msdmanuals.com/professional/pediatrics/connective-tissue-disorders-in-children/cutis-laxa.Suche in Google Scholar

3. Sinnige, PF, van Ravenswaaij-Arts, CM, Caruso, P, Lin, AB, Boon, M, Rahikkala, E, et al.. Imaging in cutis laxa syndrome caused by a dominant negative ALDH18A1 mutation, with hypotheses for intracranial vascular tortuosity and wide perivascular spaces. Eur J Paediatr Neurol 2017;21:912–20. https://doi.org/10.1016/j.ejpn.2017.07.003.Suche in Google Scholar

4. Villar, J, Ismail, LC, Victora, CG, Ohuma, EO, Bertino, E, Altman, DG, et al.. International standards for newborn weight, length, and head circumference by gestational age and sex: the newborn cross-sectional study of the INTERGROWTH-21st project. Lancet 2014;384:857–68. https://doi.org/10.1016/s0140-6736(14)60932-6.Suche in Google Scholar

5. Pascanu, I, Pop, R, Barbu, CG, Dumitrescu, CP, Gherlan, I, Marginean, O, et al.. Development of synthetic growth charts for Romanian population. Acta Endocrinol 2016;12:309–18. https://doi.org/10.4183/aeb.2016.309.Suche in Google Scholar PubMed PubMed Central

6. Koklu, E, Gunes, T, Ozturk, MA, Akcakus, M, Buyukkayhan, D, Kurtoglu, S. Cutis laxa associated with central hypothyroidism owing to isolated thyrotropin deficiency in a newborn. Pediatr Dermatol 2007;24:525–8. https://doi.org/10.1111/j.1525-1470.2007.00509.x.Suche in Google Scholar PubMed

7. Beyens, A, Boel, A, Symoens, S, Callewaert, B. Cutis laxa: a comprehensive overview of clinical characteristics and pathophysiology. Clin Genet 2021;99:53–66. https://doi.org/10.1111/cge.13865.Suche in Google Scholar PubMed

8. Andrews, A, Maharaj, A, Cottrell, E, Chatterjee, S, Shah, P, Denvir, L. Genetic characterization of short stature patients with overlapping features of growth hormone insensitivity syndromes. J Clin Endocrinol Metab 2021;106:e4716–33. https://doi.org/10.1210/clinem/dgab437.Suche in Google Scholar PubMed PubMed Central

9. Ma, Y, Zhang, JY, Wang, C, Cen, W, Liu, X, Feng, WL. Clinical presentation of a patient with congenital cutis laxa and abnormal thyroid hormone levels. Case Rep Dermatol 2014;6:43–8. https://doi.org/10.1159/000360125.Suche in Google Scholar PubMed PubMed Central

10. Med Line Plus. ALDH18A1 gene. Available from: https://medlineplus.gov/genetics/gene/aldh18a1.Suche in Google Scholar

11. The human protein atlas. Available from: https://www.proteinatlas.org/ENSG00000059573-ALDH18A1/tissue.Suche in Google Scholar

Received: 2022-01-29
Accepted: 2022-06-09
Published Online: 2022-07-01
Published in Print: 2022-09-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review Article
  3. Effects and dose-response relationships of exercise intervention on weight loss in overweight and obese children: a meta-regression and system review
  4. Original Articles
  5. Diabetic ketoacidosis in children with new-onset type 1 diabetes mellitus: demographics, risk factors and outcome: an 11 year review in Hong Kong
  6. Incidence tendency, etiological classification and outcome of congenital hypothyroidism in Guangzhou, China: an 11-year retrospective population-based study
  7. Metabolically healthy obesity in a paediatric obesity clinic
  8. Universal salt iodization potentially contributes to health equity: socio-economic status of children does not affect iodine status
  9. Association between clinical variations and copy number variations in cases with Turner syndrome
  10. The mediating function of obesity on endocrine-disrupting chemicals and insulin resistance in children
  11. Relationship between prolactin level and puberty in girls with early breast development
  12. Pattern of presentation of paediatric endocrine disorders in a Nigerian tertiary institution: an 11-year survey
  13. Case Reports
  14. Novel non-stop variant of the NR0B1 gene in two siblings with adrenal hypoplasia congenita
  15. Identification of two novel ACAT1 variant associated with beta-ketothiolase deficiency in a 9-month-old boy
  16. Craniosynostosis in a patient with Fanconi–Bickel syndrome: a case report
  17. Severe loss of adipose tissue in a Vietnamese lipodystrophy patient caused by LMNA p.G465D mutation: a first clinical characterization and two-year follow-up
  18. The response to growth hormone treatment in a child with short stature, growth hormone deficiency and autosomal dominant cutis laxa type 3 – case report
  19. Novel homozygous inactivating mutation in the luteinizing hormone receptor gene (LHCGR) associated with 46, XY DSD in a Moroccan family
Heruntergeladen am 18.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2022-0054/html
Button zum nach oben scrollen